SCHEMBL80325

SCHEMBL80325

CCCCC[CH]N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009378 0.97 TSHR (0.52)
SCHEMBL4756766 0.97 TSHR (0.52)
SCHEMBL1585548 0.97 TSHR (0.52)
SCHEMBL4754038 0.97 TSHR (0.52)
SCHEMBL4755755 0.97 TSHR (0.52)
SCHEMBL1948712 0.97 TSHR (0.52)
SCHEMBL2153463 0.97 TSHR (0.52)
SCHEMBL4757186 0.97 TSHR (0.52)
SCHEMBL4755731 0.97 TSHR (0.52)
SCHEMBL4755758 0.97 TSHR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3931 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240182955-A1 DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF Act Genomics (ip) Limited (HK) 2024-06-06 US claimed
US-20240167040-A1 ANTISENSE OLIGONUCLEOTIDE HOFFMANN LA ROCHE (US) 2024-05-23 US claimed
CN-118006613-A Aptamer-siRNA fusions 艾普特纳有限公司 2024-05-10 CN claimed
US-20240150431-A1 MHC Multimers, Methods for Their Generation, Labeling and Use DAKO DENMARK APS (DK) 2024-05-09 US claimed
EP-4361271-A2 APTAMER-SIRNA FUSIONS Apterna Limited (GB) 2024-05-01 EP claimed
CN-117412752-A Application of 4-arylaminoquinazoline hydroxamic acid compound in preparation of pain medicines 广东众生药业股份有限公司 2024-01-16 CN claimed
EP-4294945-A1 DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF Act Genomics (IP) Limited (CN) 2023-12-27 EP claimed
CN-117222750-A DNA fragment junction detection method and kit 行动基因(智财)有限公司 2023-12-12 CN claimed
CN-117126180-A Biphenyl compound as immunomodulator as well as preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-11-28 CN claimed
WO-2023167923-A1 SURFACE MODIFICATION OF NALNF4 NANOPARTICLES WITH BISPHOSPHONATE DERIVATIVES FOR MASS CYTOMETRY APPLICATIONS STANDARD BIOTOOLS CANADA INC. (CA) 2023-09-07 WO claimed
EP-0144957-A2 Process for purifying factor VIII:C Armour Pharmaceutical Company (US) 1985-06-19 EP claimed
US-4508709-A ADSORPTION, ELUTION FORM AMINOHEXYL AGAROSE ARMOUR PHARMACEUTICAL COMPANY (US) 1985-04-02 US claimed
EP-0125056-A2 Condensed, seven-membered ring compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-11-14 EP claimed
EP-0083483-A1 Ultrapurificated factor VIII : C preparation SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1983-07-13 EP claimed
WO-1983002114-A1 ULTRAPURIFICATION OF FACTOR VIII SCRIPPS CLINIC RES (US) 1983-06-23 WO claimed
US-4361509-A Ultrapurification of factor VIII using monoclonal antibodies SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1982-11-30 US claimed
US-4336188-A Method for the preparation of macromolecularized adenine derivatives SNAMPROGETTI, S.P.A. (IT) 1982-06-22 US claimed
US-4205130-A AFFINITY VHROMATORGAPHY, ISOELECTRIC FOCUSING VIHKO PIRKKO 1980-05-27 US claimed
US-3983117-A OPTICAL BRIGHTENERS BASF AKTIENGESELLSCHAFT (DT) 1976-09-28 US claimed
US-3953596-A 8-Oxa-3-azabicyclo(3.2.1)octane analgesic compositions and method of alleviating pain in animals ICI UNITED STATES INC. (US) 1976-04-27 US claimed